Role of Selective Estrogen Receptor Modulators (serm) in Treatment of Carcinoma Prostate
نویسنده
چکیده
The exact mechanism of carcinogenesis is unknown, although it is believed to involve a combination of dietary, environmental, genetic, lifestyle and hormonal causes. Prostate cancer is main problem of men, and it is believed that prostate cancer is the hormonal imbalance of the testosterone but now it has been proved clinically that estrogen hormone imbalance is also involved in the prostate carcinogenesis during the development or later period of the prostate. It required maintaining the balance of the estrogen hormone by some estrogen receptor. In this review we focused on the literature survey on Selective estrogen receptor modulators (SERMs) in prostate carcinogenesis and prevention because SERMs have shown the ability to prevent and treat prostate cancer.
منابع مشابه
The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.
Trioxifene (LY133314) is a selective estrogen receptor modulator (SERM) with competitive binding activity against estradiol for estrogen receptor alpha (ERalpha) and antagonistic activity against ERalpha-mediated gene expression. The PAIII rat prostatic adenocarcinoma (PCa) is an androgen receptor-negative, ERalpha- and ERbeta-positive, spontaneously metastatic rodent tumor cell line. After s.c...
متن کاملSelective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
Selective estrogen receptor modulators (SERMs) represent a class with a growing number of compounds that act as either estrogen receptor agonists or antagonists in a tissue-specific manner. This article reviews lasofoxifene, a new-generation SERM that has completed phase III development for the prevention and treatment of osteoporosis in postmenopausal women. Consistent with preclinical observa...
متن کاملUse of Preclinical and Early Clinical Data for Dose Selection of a Selective Estrogen Receptor Modulator Toremifene in Treatment of Breast Cancer
In development of human medicines, it is important to predict early and accurately enough the disease and patient population to be treated as well as the effective and safe dose range of the studied medicine. This is pursued by using preclinical research models, clinical pharmacology and early clinical studies with small sample sizes. When successful, this enables effective development of medic...
متن کاملAn Experimental Model of Prostatic Inflammation for Drug Discovery
There is increasing evidence to support a significant role for chronic non-bacterial prostatic inflammation in the development of human voiding dysfunction and prostate cancer. Their increased prevalence with age suggests that the decrease of testosterone concentration and/or the ratio of testosterone-to-estradiol in serum may have a role in their development. The main objective of this study w...
متن کاملSelective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins.
Proteasome-mediated protein degradation has been implicated in playing a role in nuclear receptor-mediated gene expression; inhibition of the proteasome impairs the transcriptional activity of estrogen receptor alpha (ERalpha) and most other nuclear receptors. This coincides with blockage of agonist-dependent degradation of the receptor and elevation of the steady-state levels of SRC family coa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013